Copyright
©2011 Baishideng Publishing Group Co.
World J Gastrointest Pathophysiol. Jun 15, 2011; 2(3): 35-41
Published online Jun 15, 2011. doi: 10.4291/wjgp.v2.i3.35
Published online Jun 15, 2011. doi: 10.4291/wjgp.v2.i3.35
Antibiotics | MIC in susceptible strains | MIC in resistant strains | Mechanisms of resistance |
Clarithromycin | 0.016-0.50 mg/L | ≥ 1 mg/L (2-256 mg/L) | Point mutations in rRNA |
Efflux pumps system (RND family) | |||
Metronidazole | 0.5-2 mg/L | ≥ 8 mg/L (16-128 mg/L) | Mutate NADPH reductase |
Mutate NADH oxidase | |||
Other efflux pumps | |||
Levoxacin | 0.25-0.50 mg/L | ≥ 1 mg/L (4-32 mg/L) | Point mutations in QRDR of gyrA gene |
Polymorphism in 87 codon of gyrA | |||
Amoxicillin | 0.06-0.25 mg/L | ≥ 1.0mg/L (1-8 mg/L) | Point mutations in pbp genes |
Point mutations in hpB and hpC genes | |||
Point mutations in omp25 and omp32 porin genes | |||
Tetracycline | 0.25- 2 mg/L | ≥ 4 mg/L (2-256 mg/L) | Point mutations in primary binding Tet-P site |
Point mutations in Tet-4 secondary inding site | |||
Alterations by oxidoreductase |
-
Citation: Francesco VD, Zullo A, Hassan C, Giorgio F, Rosania R, Ierardi E. Mechanisms of
Helicobacter pylori antibiotic resistance: An updated appraisal. World J Gastrointest Pathophysiol 2011; 2(3): 35-41 - URL: https://www.wjgnet.com/2150-5330/full/v2/i3/35.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v2.i3.35